NCT01975779
Source recordAI-normalized
Interventional, Randomised, Double-blind, Placebocontrolled, Single- and Multiple-ascending-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects
This clinical trial, sponsored by H. Lundbeck A/S, evaluated the safety, tolerability, and pharmacokinetics of Lu AE58054 in healthy young Japanese and Caucasian men. The study was designed as a randomized, double-blind, placebo-controlled trial with a total enrollment of 42 participants.
AI analysis
Indication: Healthy
Modality: small molecule
Target: Lu AE58054
Sponsor: H. Lundbeck A/S
Source URL: ClinicalTrials.gov
Source updated: Nov 05, 2013
Ingested: May 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Lu AE58054
View original source fields
Condition raw: Healthy
Condition normalized: Healthy
Modality raw: Healthy
Modality normalized: small molecule
Target raw: Lu AE58054
Target normalized: Lu AE58054